Latest Insider Transactions at Vericel Corp (VCEL)
This section provides a real-time view of insider transactions for Vericel Corp (VCEL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vericel Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vericel Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-13.14%
|
$490,000
$49.53 P/Share
|
|
Mar 03
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+11.61%
|
$180,000
$18.0 P/Share
|
|
Mar 03
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,000
-39.19%
|
$441,000
$49.53 P/Share
|
|
Mar 03
2025
|
Heidi Hagen |
SELL
Open market or private sale
|
Direct |
9,000
-23.9%
|
$441,000
$49.53 P/Share
|
|
Mar 03
2025
|
Heidi Hagen |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+19.29%
|
$27,000
$3.74 P/Share
|
|
Mar 03
2025
|
Michael Halpin Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
10,000
-39.16%
|
$490,000
$49.52 P/Share
|
|
Mar 03
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.28%
|
$160,000
$16.66 P/Share
|
|
Feb 25
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,137
-48.53%
|
$59,124
$52.07 P/Share
|
|
Feb 25
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,669
-68.82%
|
$86,788
$52.07 P/Share
|
|
Feb 24
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
738
-23.95%
|
$38,376
$52.33 P/Share
|
|
Feb 24
2025
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+37.83%
|
-
|
|
Feb 24
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,331
-35.44%
|
$69,212
$52.33 P/Share
|
|
Feb 24
2025
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+44.41%
|
-
|
|
Feb 24
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,358
-5.58%
|
$70,616
$52.33 P/Share
|
|
Feb 24
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,625
+15.98%
|
-
|
|
Feb 24
2025
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,486
-13.79%
|
$129,272
$52.33 P/Share
|
|
Feb 24
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,250
+22.56%
|
-
|
|
Feb 24
2025
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,459
-3.15%
|
$439,868
$52.33 P/Share
|
|
Feb 24
2025
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,250
+6.37%
|
-
|
|
Feb 24
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
636
-0.95%
|
$33,072
$52.33 P/Share
|
|
Feb 24
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+2.22%
|
-
|
|
Feb 20
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,835
-83.53%
|
$218,595
$57.32 P/Share
|
|
Feb 19
2025
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,332
-9.44%
|
$75,924
$57.78 P/Share
|
|
Feb 19
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,813
+16.63%
|
-
|
|
Feb 19
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,710
-58.64%
|
$95,760
$56.72 P/Share
|
|
Feb 19
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
777
-14.47%
|
$44,289
$57.78 P/Share
|
|
Feb 19
2025
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+24.59%
|
-
|
|
Feb 19
2025
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,196
-1.65%
|
$239,172
$57.78 P/Share
|
|
Feb 19
2025
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
8,938
+3.39%
|
-
|
|
Feb 19
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
853
-1.32%
|
$48,621
$57.78 P/Share
|
|
Feb 19
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,750
+2.64%
|
-
|
|
Feb 18
2025
|
Michael Halpin Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,389
-17.78%
|
$250,173
$57.28 P/Share
|
|
Feb 18
2025
|
Michael Halpin Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,075
+26.64%
|
-
|
|
Feb 18
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,210
-16.78%
|
$68,970
$57.28 P/Share
|
|
Feb 18
2025
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,920
+26.14%
|
-
|
|
Feb 18
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,259
-5.75%
|
$128,763
$57.28 P/Share
|
|
Feb 18
2025
|
Joseph Anthony Mara Jr Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,379
+15.62%
|
-
|
|
Feb 18
2025
|
Sean C. Flynn Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,463
-30.15%
|
$140,391
$57.28 P/Share
|
|
Feb 18
2025
|
Sean C. Flynn Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,325
+38.87%
|
-
|
|
Feb 18
2025
|
Dominick Colangelo President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,423
-2.16%
|
$309,111
$57.28 P/Share
|
|
Feb 18
2025
|
Dominick Colangelo President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
29,950
+5.77%
|
-
|
|
Feb 18
2025
|
Jonathan Mark Hopper Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
985
-1.54%
|
$56,145
$57.28 P/Share
|
|
Feb 18
2025
|
Jonathan Mark Hopper Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,325
+4.08%
|
-
|
|
Feb 12
2025
|
Kevin F Mclaughlin |
SELL
Open market or private sale
|
Direct |
7,000
-20.64%
|
$385,000
$55.45 P/Share
|
|
Feb 12
2025
|
Kevin F Mclaughlin |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+16.15%
|
$21,000
$3.25 P/Share
|
|
Feb 07
2025
|
Alan L Rubino |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+19.27%
|
$57,000
$3.74 P/Share
|
|
Feb 05
2025
|
Robert L Md Zerbe |
SELL
Open market or private sale
|
Direct |
2,500
-8.59%
|
$155,000
$62.5 P/Share
|
|
Feb 05
2025
|
Robert L Md Zerbe |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+7.91%
|
$32,500
$13.05 P/Share
|
|
Feb 05
2025
|
Jonathan Siegal Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,092
-47.52%
|
$66,612
$61.99 P/Share
|
|
Feb 05
2025
|
Jonathan Siegal Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,092
+32.21%
|
$52,416
$48.8 P/Share
|